Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma

After unprecedented successes in B-cell malignancies, chimeric antigen receptor T cells have recently been investigated for the treatment of multiple myeloma. Chimeric antigen receptor targeting T cells B-cell maturation antigen (BCMA) on malignant plasma cells have led to impressive clinical respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chuang, Mahendravada, Aruna, Ballard, Brandon, Kale, Brandon, Ramos, Carlos, West, John, Maguire, Todd, McKay, Katie, Lichtman, Eben, Tuchman, Sascha, Dotti, Gianpietro, Savoldo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481321/
https://www.ncbi.nlm.nih.gov/pubmed/31040928
http://dx.doi.org/10.18632/oncotarget.26792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481321/
https://www.ncbi.nlm.nih.gov/pubmed/31040928
http://dx.doi.org/10.18632/oncotarget.26792

Ejemplares similares